Lemonade (LMND) Competitors $56.66 +4.09 (+7.78%) Closing price 03:59 PM EasternExtended Trading$56.95 +0.29 (+0.51%) As of 05:34 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LMND vs. UPST, ALL, PGR, AEG, RYAN, EG, GL, KNSL, BNRE, and VOYAShould you be buying Lemonade stock or one of its competitors? The main competitors of Lemonade include Upstart (UPST), Allstate (ALL), Progressive (PGR), Aegon (AEG), Ryan Specialty (RYAN), Everest Group (EG), Globe Life (GL), Kinsale Capital Group (KNSL), Brookfield Reinsurance (BNRE), and Voya Financial (VOYA). These companies are all part of the "finance" sector. Lemonade vs. Its Competitors Upstart Allstate Progressive Aegon Ryan Specialty Everest Group Globe Life Kinsale Capital Group Brookfield Reinsurance Voya Financial Upstart (NASDAQ:UPST) and Lemonade (NYSE:LMND) are both mid-cap finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, risk, valuation, analyst recommendations, media sentiment, earnings, dividends and profitability. Do analysts recommend UPST or LMND? Upstart presently has a consensus target price of $78.54, suggesting a potential upside of 17.26%. Lemonade has a consensus target price of $40.43, suggesting a potential downside of 28.65%. Given Upstart's stronger consensus rating and higher probable upside, research analysts clearly believe Upstart is more favorable than Lemonade.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Upstart 1 Sell rating(s) 7 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.36Lemonade 4 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 1.86 Is UPST or LMND more profitable? Upstart has a net margin of -0.75% compared to Lemonade's net margin of -33.96%. Upstart's return on equity of -5.95% beat Lemonade's return on equity.Company Net Margins Return on Equity Return on Assets Upstart-0.75% -5.95% -1.75% Lemonade -33.96%-36.12%-10.93% Which has more volatility & risk, UPST or LMND? Upstart has a beta of 2.37, indicating that its share price is 137% more volatile than the S&P 500. Comparatively, Lemonade has a beta of 2.27, indicating that its share price is 127% more volatile than the S&P 500. Does the media refer more to UPST or LMND? In the previous week, Lemonade had 3 more articles in the media than Upstart. MarketBeat recorded 5 mentions for Lemonade and 2 mentions for Upstart. Upstart's average media sentiment score of 1.20 beat Lemonade's score of 0.75 indicating that Upstart is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Upstart 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lemonade 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders & institutionals believe in UPST or LMND? 63.0% of Upstart shares are held by institutional investors. Comparatively, 80.3% of Lemonade shares are held by institutional investors. 16.7% of Upstart shares are held by insiders. Comparatively, 12.5% of Lemonade shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has better valuation & earnings, UPST or LMND? Upstart has higher revenue and earnings than Lemonade. Upstart is trading at a lower price-to-earnings ratio than Lemonade, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpstart$636.53M10.12-$128.58M-$0.08-837.25Lemonade$526.50M7.95-$202.20M-$2.83-20.02 SummaryUpstart beats Lemonade on 13 of the 17 factors compared between the two stocks. Get Lemonade News Delivered to You Automatically Sign up to receive the latest news and ratings for LMND and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LMND and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LMND vs. The Competition Export to ExcelMetricLemonadeINS IndustryFinance SectorNYSE ExchangeMarket Cap$4.19B$21.41B$12.64B$21.50BDividend YieldN/A2.56%5.40%3.49%P/E Ratio-20.0214.01244.6529.86Price / Sales7.952.5030.7051.75Price / CashN/A17.5519.2518.13Price / Book6.823.722.314.65Net Income-$202.20M$1.62B$1.01B$999.94M7 Day Performance7.10%-0.16%0.65%0.79%1 Month Performance-1.19%0.25%3.19%4.55%1 Year Performance210.64%19.21%543.60%16.77% Lemonade Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LMNDLemonade2.7026 of 5 stars$56.66+7.8%$40.43-28.6%+188.0%$4.19B$526.50M-20.021,235Options VolumeUPSTUpstart4.2801 of 5 stars$68.17+1.9%$78.54+15.2%+65.9%$6.55B$636.53M-850.841,193Positive NewsGap UpALLAllstate4.9635 of 5 stars$200.41-0.6%$231.21+15.4%+6.4%$52.81B$64.11B9.4255,400Positive NewsShort Interest ↑PGRProgressive4.7184 of 5 stars$246.12+0.9%$284.18+15.5%-2.8%$144.28B$75.37B13.8766,308Positive NewsAnalyst UpgradeAEGAegon4.4947 of 5 stars$7.59+0.9%N/A+29.5%$15.22B$10.65B7.9023,123Analyst UpgradeShort Interest ↓RYANRyan Specialty4.7763 of 5 stars$54.12-0.5%$74.83+38.3%-19.4%$14.27B$2.52B154.625,250Insider TradeGap UpEGEverest Group4.8356 of 5 stars$339.63-0.1%$397.14+16.9%-8.7%$14.24B$17.28B18.033,037Positive NewsGLGlobe Life4.8375 of 5 stars$140.42+0.4%$152.45+8.6%+37.0%$11.37B$5.78B11.223,732Positive NewsKNSLKinsale Capital Group3.9888 of 5 stars$453.12-0.5%$505.80+11.6%-7.0%$10.56B$1.59B23.64470Positive NewsBNREBrookfield ReinsuranceN/A$66.58-0.2%N/A+37.8%$9.69B$9.35B229.5960News CoverageHigh Trading VolumeVOYAVoya Financial4.974 of 5 stars$75.73-1.0%$83.70+10.5%+2.8%$7.30B$8.05B15.1510,000News CoveragePositive News Related Companies and Tools Related Companies Upstart Competitors Allstate Competitors Progressive Competitors Aegon Competitors Ryan Specialty Competitors Everest Group Competitors Globe Life Competitors Kinsale Capital Group Competitors Brookfield Reinsurance Competitors Voya Financial Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:LMND) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lemonade, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Lemonade With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LMND Stock Alerts